Dendritic Cells in Hematopoietic Cell Transplantation

[1]  J. Villadangos,et al.  Found in translation: the human equivalent of mouse CD8+ dendritic cells , 2010, The Journal of experimental medicine.

[2]  F. Ginhoux,et al.  Ontogeny and homeostasis of Langerhans cells , 2010, Immunology and cell biology.

[3]  B. Malissen,et al.  Disentangling the complexity of the skin dendritic cell network , 2010, Immunology and cell biology.

[4]  F. Ginhoux,et al.  Origin and functional heterogeneity of non‐lymphoid tissue dendritic cells in mice , 2010, Immunological reviews.

[5]  J. Rodriguez-Barbosa,et al.  Development and functional specialization of CD103+ dendritic cells , 2010, Immunological reviews.

[6]  W. Agace,et al.  Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions , 2009, The Journal of experimental medicine.

[7]  F. Ginhoux,et al.  The origin and development of nonlymphoid tissue CD103+ DCs , 2009, The Journal of experimental medicine.

[8]  D. Munn,et al.  Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. , 2009, Blood.

[9]  F. Ginhoux,et al.  Origin of the lamina propria dendritic cell network. , 2009, Immunity.

[10]  Steffen Jung,et al.  Intestinal lamina propria dendritic cell subsets have different origin and functions. , 2009, Immunity.

[11]  J. Villadangos,et al.  Antigen presentation by dendritic cells in vivo. , 2009, Current opinion in immunology.

[12]  F. Ginhoux,et al.  Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells , 2008, Nature Reviews Immunology.

[13]  E. Engleman,et al.  Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo1 , 2008, The Journal of Immunology.

[14]  C. Dinarello,et al.  Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. , 2008, The Journal of clinical investigation.

[15]  Antal Rot,et al.  CCR7 and its ligands: balancing immunity and tolerance , 2008, Nature Reviews Immunology.

[16]  P. Allavena,et al.  The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance , 2008, Immunological reviews.

[17]  Gwendalyn J Randolph,et al.  Migration of dendritic cell subsets and their precursors. , 2008, Annual review of immunology.

[18]  Eric Vivier,et al.  Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling , 2008, Genome Biology.

[19]  N. Van Rooijen,et al.  Dendritic Cell-Induced Memory T Cell Activation in Nonlymphoid Tissues , 2008, Science.

[20]  F. Ginhoux,et al.  Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state , 2007, The Journal of experimental medicine.

[21]  L. Klareskog,et al.  Natural killer cells trigger differentiation of monocytes into dendritic cells. , 2007, Blood.

[22]  M. Merad,et al.  Dendritic cell homeostasis and trafficking in transplantation. , 2007, Trends in immunology.

[23]  J. Villadangos,et al.  Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo , 2007, Nature Reviews Immunology.

[24]  M. Nussenzweig,et al.  Origin of dendritic cells in peripheral lymphoid organs of mice , 2007, Nature Immunology.

[25]  J. Powell,et al.  Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. , 2007, Blood.

[26]  G. Besra,et al.  NKT cells direct monocytes into a DC differentiation pathway , 2007, Journal of leukocyte biology.

[27]  B. León,et al.  Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. , 2007, Immunity.

[28]  J. Lau,et al.  Activated Circulating Dendritic Cells After Hematopoietic Stem Cell Transplantation Predict Acute Graft-Versus-Host Disease , 2007, Transplantation.

[29]  M. Gross,et al.  Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes , 2007, Nature Immunology.

[30]  M. Tanimoto,et al.  Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. , 2007, Blood.

[31]  M. Baccarani,et al.  Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  M. Miñana,et al.  The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation , 2007, Transfusion.

[33]  Steffen Jung,et al.  Monocytes give rise to mucosal, but not splenic, conventional dendritic cells , 2007, The Journal of experimental medicine.

[34]  F. Claas,et al.  A Uniform Genomic Minor Histocompatibility Antigen Typing Methodology and Database Designed to Facilitate Clinical Applications , 2006, PloS one.

[35]  F. Ginhoux,et al.  Identification of a radio-resistant and cycling dermal dendritic cell population in mice and men , 2006, The Journal of experimental medicine.

[36]  M. Caligiuri,et al.  Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. , 2006, Blood.

[37]  G. Murphy,et al.  Host-Derived Langerhans Cells Persist after MHC-Matched Allografting Independent of Donor T Cells and Critically Influence the Alloresponses Mediated by Donor Lymphocyte Infusions1 , 2006, The Journal of Immunology.

[38]  T. Banović,et al.  Host B cells produce IL-10 following TBI and attenuate acute GVHD after allogeneic bone marrow transplantation. , 2006, Blood.

[39]  M. Sykes,et al.  Host MHC class II+ antigen-presenting cells and CD4 cells are required for CD8-mediated graft-versus-leukemia responses following delayed donor leukocyte infusions. , 2006, Blood.

[40]  V. Pascual,et al.  Type I interferon in systemic lupus erythematosus and other autoimmune diseases. , 2006, Immunity.

[41]  Charles P. Lin,et al.  An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues , 2006, The Journal of experimental medicine.

[42]  P. Fu,et al.  Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[43]  C. Sousa,et al.  Dendritic cells in a mature age , 2006, Nature Reviews Immunology.

[44]  A. Chorny,et al.  Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response. , 2006, Blood.

[45]  I. Todorov,et al.  Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. , 2006, Blood.

[46]  Bryon D Johnson,et al.  Graft-versus-leukemia and graft-versus-host reactions after donor lymphocyte infusion are initiated by host-type antigen-presenting cells and regulated by regulatory T cells in early and long-term chimeras. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[47]  K. Schäkel,et al.  Fast Appearance of Donor Dendritic Cells in Human Skin: Dynamics of Skin and Blood Dendritic Cells after Allogeneic Hematopoietic Cell Transplantation , 2006, Transplantation.

[48]  P. Tiberghien,et al.  Association of Mixed Hematopoietic Chimerism with Elevated Circulating Autoantibodies and Chronic Graft-versus-Host Disease Occurrence , 2006, Transplantation.

[49]  R. Steinman,et al.  Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Ono,et al.  NK026680, a novel compound suppressive of dendritic cell function, ameliorates mortality in acute lethal graft-versus-host reaction in mice , 2006, Bone Marrow Transplantation.

[51]  F. Ginhoux,et al.  Langerhans cells arise from monocytes in vivo , 2006, Nature Immunology.

[52]  S. Mackinnon,et al.  The fate of human Langerhans cells in hematopoietic stem cell transplantation , 2006, The Journal of experimental medicine.

[53]  R. Bouabdallah,et al.  Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation. , 2005, Blood.

[54]  P. Calabresi,et al.  Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Korngold,et al.  A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses , 2005, Nature Medicine.

[56]  E. Holler,et al.  Peripheral Dendritic Cell Chimerism in Allogeneic Hematopoietic Stem Cell Recipients , 2005, Transplantation.

[57]  S. Ledbetter,et al.  TGF-β in allogeneic stem cell transplantation: friend or foe? , 2005 .

[58]  Beatriz León,et al.  Monocyte-derived dendritic cells. , 2005, Seminars in immunology.

[59]  Melody A. Swartz,et al.  Dendritic-cell trafficking to lymph nodes through lymphatic vessels , 2005, Nature Reviews Immunology.

[60]  S. Saeland,et al.  Cutaneous dendritic cells. , 2005, Seminars in immunology.

[61]  R. Steinman,et al.  Dendritic cell maturation by innate lymphocytes , 2005, The Journal of experimental medicine.

[62]  E. Wagner,et al.  BCR/ABL promotes dendritic cell-mediated natural killer cell activation. , 2005, Cancer research.

[63]  S. Eo,et al.  Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells. , 2005, Blood.

[64]  C. Mackall,et al.  Age-dependent incidence, time course, and consequences of thymic renewal in adults , 2005 .

[65]  A. Dickinson,et al.  In Vitro Depletion of Tissue-Derived Dendritic Cells by CMRF-44 Antibody and Alemtuzumab: Implications for the Control of Graft-Versus-Host Disease , 2005, Transplantation.

[66]  J. Mora,et al.  Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues , 2005, The Journal of experimental medicine.

[67]  G. Trinchieri,et al.  Plasmacytoid dendritic cells in immunity , 2004, Nature Immunology.

[68]  D. Jain,et al.  Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. , 2004, Blood.

[69]  D. Jain,et al.  Target Antigens Determine Graft-versus-Host Disease Phenotype , 2004, The Journal of Immunology.

[70]  Gabrielle T Belz,et al.  Cognate CD4+ T cell licensing of dendritic cells in CD8+ T cell immunity , 2004, Nature Immunology.

[71]  J. Radich,et al.  Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. , 2004, Blood.

[72]  T. Blankenstein,et al.  CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. , 2004, Immunity.

[73]  D. Jain,et al.  Donor APCs are required for maximal GVHD but not for GVL , 2004, Nature Medicine.

[74]  F. Locatelli,et al.  Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation. , 2004, Blood.

[75]  U. Duffner,et al.  Host Dendritic Cells Alone Are Sufficient to Initiate Acute Graft-versus-Host Disease1 , 2004, The Journal of Immunology.

[76]  J. Schold,et al.  Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. , 2004, Blood.

[77]  D. Steindler,et al.  Bone marrow transdifferentiation in brain after transplantation: a retrospective study , 2004, The Lancet.

[78]  S. Riddell,et al.  Molecules and mechanisms of the graft-versus-leukaemia effect , 2004, Nature Reviews Cancer.

[79]  J. Serody,et al.  In vivo imaging of graft-versus-host-disease in mice. , 2004, Blood.

[80]  Irving L Weissman,et al.  Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease , 2004, Nature Medicine.

[81]  J. Pober,et al.  T lymphocyte-endothelial cell interactions. , 2004, Annual review of immunology.

[82]  W. Hoetzenecker,et al.  Corticosteroids but not pimecrolimus affect viability, maturation and immune function of murine epidermal Langerhans cells. , 2004, The Journal of investigative dermatology.

[83]  S. Mackinnon,et al.  Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses. , 2004, Blood.

[84]  M. Baccarani,et al.  Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[85]  A. Barrett,et al.  Review Articles (434 articles) , 2003 .

[86]  Stephen C. Jones,et al.  Importance of minor histocompatibility antigen expression by nonhematopoietic tissues in a CD4+ T cell-mediated graft-versus-host disease model. , 2003, The Journal of clinical investigation.

[87]  W. Shlomchik.  Antigen presentation in graft-vs-host disease. , 2003, Experimental hematology.

[88]  R. Steinman,et al.  Tolerogenic dendritic cells. , 2003, Annual review of immunology.

[89]  M. Baccarani,et al.  Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant. , 2003, Experimental hematology.

[90]  M. Haun,et al.  Phenotype, function and chimaerism of monocyte‐derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation , 2003, British journal of haematology.

[91]  J. Ferrara,et al.  The Pathophysiology of Acute Graft-versus-Host Disease , 2003, International journal of hematology.

[92]  C. Fathman,et al.  CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation , 2003, Nature Medicine.

[93]  A. Panoskaltsis-Mortari,et al.  Blockade of Programmed Death-1 Engagement Accelerates Graft-Versus-Host Disease Lethality by an IFN-γ-Dependent Mechanism1 , 2003, The Journal of Immunology.

[94]  M. Maris,et al.  Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. , 2003, Blood.

[95]  Chen Liu,et al.  Impaired thymic negative selection causes autoimmune graft-versus-host disease. , 2003, Blood.

[96]  Wolfgang Weninger,et al.  Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells , 2003, Nature.

[97]  Katsuaki Sato,et al.  Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. , 2003, Blood.

[98]  R. Bronson,et al.  Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. , 2003, The Journal of clinical investigation.

[99]  Katsuaki Sato,et al.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. , 2003, Immunity.

[100]  K. Busam,et al.  Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation. , 2003, Blood.

[101]  C. Craddock,et al.  Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease1 , 2003, Transplantation.

[102]  Jiang Zhu,et al.  APCs in the Liver and Spleen Recruit Activated Allogeneic CD8+ T Cells to Elicit Hepatic Graft-Versus-Host Disease1 , 2002, The Journal of Immunology.

[103]  K. MacDonald,et al.  Characterization of human blood dendritic cell subsets. , 2002, Blood.

[104]  I. Weissman,et al.  Langerhans cells renew in the skin throughout life under steady-state conditions , 2002, Nature Immunology.

[105]  J. Cavenagh,et al.  The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation. , 2002, Blood.

[106]  D. Tough,et al.  Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. , 2002, Blood.

[107]  J. Salisbury,et al.  Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab. , 2002, Blood.

[108]  W. Landuyt,et al.  Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. , 2002, Blood.

[109]  P. Brossart,et al.  Activated CD8+ T lymphocytes induce differentiation of monocytes to dendritic cells and restore the stimulatory capacity of interleukin 10-treated antigen-presenting cells. , 2002, Cancer research.

[110]  R. Bronson,et al.  Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. , 2002, Blood.

[111]  Steffen Jung,et al.  In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. , 2002, Immunity.

[112]  H. Lyerly,et al.  Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants. , 2002, Journal of hematotherapy & stem cell research.

[113]  J. Ferrara,et al.  Acute graft-versus-host disease does not require alloantigen expression on host epithelium , 2002, Nature Medicine.

[114]  Jiang Zhu,et al.  Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. , 2002, The Journal of clinical investigation.

[115]  M. Schroeder.  Transfusion-associated graft-versus-host disease. , 2002, British journal of haematology.

[116]  N. Russell,et al.  Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution. , 2002, Blood.

[117]  Yong‐jun Liu,et al.  Mouse and human dendritic cell subtypes , 2002, Nature Reviews Immunology.

[118]  I. Lossos,et al.  Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients. , 2002, Blood.

[119]  J. Crawford,et al.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation. , 2001, The Journal of clinical investigation.

[120]  S. Fujii,et al.  Treatment of Post-Transplanted, Relapsed Patients with Hematological Malignancies by Infusion of HLA-Matched, Allogeneic-Dendritic Cells (DCs) Pulsed with Irradiated Tumor Cells and Primed T Cells , 2001, Leukemia & lymphoma.

[121]  S. Miltenyi,et al.  BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.

[122]  T. Luger,et al.  Mycophenolate Mofetil Impairs the Maturation and Function of Murine Dendritic Cells1 , 2000, The Journal of Immunology.

[123]  B. Pulendran,et al.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. , 2000, Blood.

[124]  S. Heimfeld,et al.  Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. , 2000, Blood.

[125]  G. Hill,et al.  G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. , 2000, Transplantation.

[126]  D. Sachs,et al.  Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. , 2000, The Journal of clinical investigation.

[127]  T. Ito,et al.  A CD1a+/CD11c+ subset of human blood dendritic cells is a direct precursor of Langerhans cells. , 1999, Journal of immunology.

[128]  M. Shlomchik,et al.  Prevention of graft versus host disease by inactivation of host antigen-presenting cells. , 1999, Science.

[129]  G. Hill,et al.  Pretransplant chemotherapy reduces inflammatory cytokine production and acute graft-versus-host disease after allogeneic bone marrow transplantation. , 1999, Transplantation.

[130]  N. Kadowaki,et al.  The nature of the principal type 1 interferon-producing cells in human blood. , 1999, Science.

[131]  P. Allavena,et al.  Glucocorticoids affect human dendritic cell differentiation and maturation. , 1999, Journal of immunology.

[132]  S L Walker,et al.  Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. , 1999, The Journal of investigative dermatology.

[133]  N. Kadowaki,et al.  Reciprocal control of T helper cell and dendritic cell differentiation. , 1999, Science.

[134]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[135]  N. Young,et al.  T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect , 1998, Bone Marrow Transplantation.

[136]  D. Hart,et al.  Dendritic cells: unique leukocyte populations which control the primary immune response. , 1997, Blood.

[137]  I. Kimber,et al.  Langerhans cells require signals from both tumour necrosis factor‐α and interleukin‐1β for migration , 1997, Immunology.

[138]  J. Crawford,et al.  Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. , 1997, Blood.

[139]  J. Abkowitz,et al.  Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. , 1997, Blood.

[140]  L. Dubertret,et al.  Langerhans' cells are depleted in chronic graft versus host disease. , 1997, Journal of clinical pathology.

[141]  E. Holler,et al.  Adoptive immunotherapy with donor lymphocyte transfusions. , 1997, Current opinion in oncology.

[142]  H. Zitzelsberger,et al.  Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation , 1996, Histochemistry and Cell Biology.

[143]  J. Ferrara,et al.  Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. , 1996, Blood.

[144]  K. Cooper,et al.  In human dermis, ultraviolet radiation induces expansion of a CD36+ CD11b+ CD1- macrophage subset by infiltration and proliferation; CD1+ Langerhans-like dendritic antigen-presenting cells are concomitantly depleted. , 1995, The Journal of investigative dermatology.

[145]  S. Ullrich.  THE ROLE OF EPIDERMAL CYTOKINES IN THE GENERATION OF CUTANEOUS IMMUNE REACTIONS and ULTRAVIOLET RADIATION‐INDUCED IMMUNE SUPPRESSION , 1995, Photochemistry and photobiology.

[146]  S. Mackinnon,et al.  Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. , 1995, Blood.

[147]  R. Truitt,et al.  Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. , 1995, Blood.

[148]  Johan,et al.  Functional expression of adhesion receptors and costimulatory molecules by fresh and immortalized B-cell non-Hodgkin's lymphoma cells. , 1995, Blood.

[149]  J. Pollard,et al.  Osteopetrotic (op/op) mice deficient in macrophages have the ability to mount a normal T-cell-dependent immune response. , 1995, Cellular immunology.

[150]  O. Griffith,et al.  Inhibition of nitric oxide production is associated with enhanced weight loss, decreased survival, and impaired alloengraftment in mice undergoing graft-versus-host disease after bone marrow transplantation , 1994 .

[151]  R. Steinman,et al.  Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. , 1994, Immunology.

[152]  R. Steinman,et al.  Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium , 1993, The Journal of experimental medicine.

[153]  L. Davis,et al.  Isolation and characterization of human peripheral blood dendritic cells. , 1993, Journal of immunology.

[154]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[155]  J. Sprent,et al.  Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen- presenting cells in vivo , 1992, The Journal of experimental medicine.

[156]  R. Steinman,et al.  Identification of proliferating dendritic cell precursors in mouse blood , 1992, The Journal of experimental medicine.

[157]  F. P. Nestel,et al.  Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease , 1992, The Journal of experimental medicine.

[158]  R. Thompson,et al.  Inhibition of interleukin-1 by an interleukin-1 receptor antagonist prevents graft-versus-host disease. , 1991, Blood.

[159]  Rachel L. Mistur,et al.  Graft-Versus-Host Disease , 2016 .

[160]  Bin Wang,et al.  Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[161]  E. Engleman,et al.  Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. , 1990, The Journal of clinical investigation.

[162]  W. Morison.  EFFECTS OF ULTRAVIOLET RADIATION ON THE IMMUNE SYSTEM IN HUMANS , 1989, Photochemistry and photobiology.

[163]  S. Hsu,et al.  Self‐Renewal of Pulmonary Alveolar Macrophages: Evidence From Radiation Chimera Studies , 1987, Journal of leukocyte biology.

[164]  Y. DeClerck,et al.  Clonal analysis of murine graft-vs-host disease. II. Leukokines that stimulate fibroblast proliferation and collagen synthesis in graft-vs. host disease. , 1986, Journal of immunology.

[165]  R. Parkman.  Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones. , 1986, Journal of immunology.

[166]  J. Sprent,et al.  Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences , 1986, The Journal of experimental medicine.

[167]  K. Atkinson,et al.  Mononuclear cell subpopulations in the skin defined by monoclonal antibodies after HLA‐identical sibling marrow transplantation , 1986, The British journal of dermatology.

[168]  C. Perreault,et al.  Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft‐versus‐host disease , 1985, British journal of haematology.

[169]  S. Lee,et al.  Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80 , 1985, The Journal of experimental medicine.

[170]  M. Mihm,et al.  Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans. , 1985, The Journal of investigative dermatology.

[171]  S. Imrie,et al.  Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients. , 1984, Journal of clinical pathology.

[172]  C. Perreault,et al.  Study of Langerhans cells after allogeneic bone marrow transplantation. , 1984, Blood.

[173]  M. Feldmann,et al.  ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITY , 1983, The Lancet.

[174]  J. Sprent,et al.  Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers , 1982, The Journal of experimental medicine.

[175]  C. E. Ford,et al.  Cytological Identification of Radiation-Chimæras , 1956, Nature.

[176]  S. Nedospasov,et al.  Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation. , 2006, Blood.

[177]  S. Boeck,et al.  Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients , 2006, Bone Marrow Transplantation.

[178]  D. Olive,et al.  Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation , 2005, Leukemia.

[179]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.

[180]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[181]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[182]  D. Hart,et al.  Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation. , 1999, Blood.

[183]  L. Sherman,et al.  The molecular basis of allorecognition. , 1993, Annual review of immunology.